Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population.
about
The PCSK9 decadeFrom proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implicationsProprotein convertase subtilisin/kexin type 9 expression is transiently up-regulated in the acute period of myocardial infarction in rat.Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol.Determining the binding affinity of therapeutic monoclonal antibodies towards their native unpurified antigens in human serum.Lack of a relationship between plasma PCSK9 concentrations and hepatic lipoprotein kinetics in obese peopleAssessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platformsCirculating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study.Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor Cells.Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery diseaseDyslipidemia in rat fed with high-fat diet is not associated with PCSK9-LDL-receptor pathway but ageing.Lipid lowering with PCSK9 inhibitors.The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Cardiovascular Homeostasis: A Non-Systematic Literature Review.Investigating cholesterol metabolism and ageing using a systems biology approach.Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women.Positive correlation of plasma PCSK9 levels with HbA1c in patients with type 2 diabetes.Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.Isolation and characterization of the circulating truncated form of PCSK9Association of IFITM3 rs12252 polymorphisms, BMI, diabetes, and hypercholesterolemia with mild flu in an Iranian population.Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9.Circulating PCSK9 levels and 2-hPG are positively correlated in metabolic diseases in a Chinese Han population.Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery diseaseResponse: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome (Diabetes Metab J 2018;42:207-14)
P2860
Q24615397-5D34A3EC-5B78-4347-BBFA-19BDF886E3E3Q26741078-F5E69B1D-23FE-47F4-88B4-AF600F7267C7Q34789111-8FF991EB-C8AF-47AE-A443-6DDBA835432BQ35014317-162385F8-D39D-4A88-9D4F-AA30A0462B10Q35040430-72CB358D-EFF4-4872-AFF6-360B4C91F035Q35436046-3A70A594-ED65-4770-A3A9-E44AEF9E0E7AQ35864980-B4AB0703-8409-49B8-94A8-DF73F1A7AF56Q36362512-1FB37090-BA6C-4407-B8F8-0A057DAF3710Q36956822-9E357A00-904E-4C13-923E-5EB10D82B3BFQ37278608-32F469B7-7C3D-4D77-8898-1440096D7443Q37466735-47C80AE0-DBF8-4004-9B8E-84CEF75A4884Q38222649-FFC79C36-12CB-4060-AC43-D33607184919Q38637552-DA64D00F-1CA5-46EF-BD3C-1A28CF092883Q38996605-07284338-D2FA-4A71-AA76-9BDF90CB7245Q39017494-0150B69E-8C2B-4F6E-B37A-23E522B719C2Q40532465-FCC09DE1-A082-4E06-9D79-9128D8D9CA20Q40899815-A9E980F6-6016-4BDE-B7F5-E7667F6813C8Q41518234-25A93734-6704-4029-BB1B-76E76B692D19Q47099485-244FEF62-902D-45E2-A897-D9079703C662Q47101735-5ACE1FBE-DCE7-479B-9423-285206A936E3Q49269198-5A94049F-0A6A-4B01-954A-7FCC01001666Q52721601-CC3190C5-D3D4-43F4-8949-D40C9917EB40Q58258510-88CEC3FB-C9AA-4505-9A5A-AC44FB139479Q58730027-4692542C-DCD6-472C-8ED9-354B4BB95168
P2860
Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Serum PCSK9 is associated with ...... large Han Chinese population.
@en
Serum PCSK9 is associated with ...... large Han Chinese population.
@nl
type
label
Serum PCSK9 is associated with ...... large Han Chinese population.
@en
Serum PCSK9 is associated with ...... large Han Chinese population.
@nl
prefLabel
Serum PCSK9 is associated with ...... large Han Chinese population.
@en
Serum PCSK9 is associated with ...... large Han Chinese population.
@nl
P2093
P1433
P1476
Serum PCSK9 is associated with ...... large Han Chinese population.
@en
P2093
Guoqing Cao
Hongwen Zhou
Jason S Troutt
Joseph V Haas
Richard T Pickard
Robert J Konrad
Ryan Darling
P304
P356
10.1016/J.ATHEROSCLEROSIS.2010.09.027
P577
2010-10-30T00:00:00Z